|
|
|
Volumn 2, Issue 1, 2000, Pages 40-59
|
|
Inhibitors of cyclin-dependent kinases as therapeutic agents for the treatment of cancer
a
|
|
Author keywords
Cancer; CDK inhibitor; Cell cycle; p53; Rb; Signal transduction
|
|
Indexed keywords
2 (3 CHLOROANILINO) 4 [2 (3 HYDROXYPROPYLAMINO) 4 PYRIDYL]PYRIMIDINE;
2 BIS(2 HYDROXYETHYL)AMINO 9 ISOPROPYL 6 (4 METHOXYBENZYLAMINO)PURINE;
2 THIOFLAVOPIRIDOL DERIVATIVE;
2,6 DIAMINO 4 CYCLOHEXYLMETHOXY 5 NITROSOPYRIMIDINE;
6 N,N DIMETHYLADENINE;
6 O CYCLOHEXYLMETHYLGUANINE;
AG 12275;
AG 12286;
BUTYROLACTONE 1;
CYCLIN DEPENDENT KINASE INHIBITOR;
FLAVONE DERIVATIVE;
FLAVOPIRIDOL;
INDIRUBIN;
INDOLE DERIVATIVE;
MDL 33;
N METHYL 4 [2 (2 OXOPYRIDO[2,3 E]INDOL 3 YLIDENE)HYDRAZINO]PHENYLMETHANESULFONAMIDE;
N METHYL 4 [2 (7 OXOTHIAZOLO[4,5 E]INDOL 8 YLIDENE)HYDRAZINO]BENZENESULFONAMIDE;
OLOMOUCINE;
OXINDOLE 1;
PD 171851;
PD 172803;
PROTEIN P53;
PURINE DERIVATIVE;
PURVALANOL A;
PYRIMIDINE DERIVATIVE;
ROSCOVITINE;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WO 09716447;
WO 09924416;
CANCER;
CANCER THERAPY;
CELL CYCLE;
CLINICAL TRIAL;
DRUG ACTIVITY;
DRUG STRUCTURE;
ENZYME INHIBITION;
HUMAN;
INFLAMMATION;
NONHUMAN;
REVIEW;
SIGNAL TRANSDUCTION;
|
|
EID: 0034033642
PISSN: 14648466
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (37)
|
|
References (218)
|
